explore -WSS

explore

author：leisure time 2025-09-27 12:55:51 - browse：79522

Anna Yeo/STAT

Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle cell anemia and beta thalassemia. But “one-time” miracle solutions can often be multi-month affairs, require millions of dollars, and cause painful side effects. What if that doesn’t have to be the case?

In utero gene editing, or prenatal somatic cell genome editing, envisions treating a fetus diagnosed with a genetic disease before birth, thereby preventing that entire protocol and the onset of symptoms in the first place. It would also challenge the need for the ethically fraught enterprise of embryo editing, as the treatment would only make edits in the DNA of the individual fetus — edits which would not be passed on in a heritable way.

Watch this video to learn more about in utero gene editing, how it works, and why scientists believe it might be an advantageous approach to treating certain genetic diseases.

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： UnitedHealth CEO's Medicaid comments send insurer stocks diving

hotspot

focus

WSS

Kidney transplant patients stopped immunosuppressants in trial

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

The most pressing bird flu mysteries scientists want answered

Eli Lilly’s Zepbound improved liver scarring in mid

CMS got Medicare Advantage quality rating wrong, judge rules

After Sarepta trial failure, Duchenne families brace for more debate

focus

explore

leisure time

In Memoriam: Notable people who died in 2023

Explaining an after

Heart attack and stroke risk calculators need revising

Data don't support strong claims for Covid

In Memoriam: Notable people who died in 2023

Illumina board agrees to spin off Grail, as divestment plans proceed

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Fight over Supreme Court dialysis ruling puts kidney patients at risk

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

STAT wants to know your pick for a great summer read or listen

Wikipedia

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Anthony Fauci pushes back on GOP claims during Covid hearing

Explaining an after

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Key Senate panel to consider PBM, drug pricing reform package

hotspot

leisure time

focus

explore